Podcasts about Myasthenia gravis

Myasthenia Gravis is a rare, chronic autoimmune disease that disrupts lives, yet it remains largely invisible in healthcare systems and policy discussions across Europe.  In this episode of Brain Talks, host Sam Pauly speaks with patient advocate Lutgarde Allard (European Myasthenia Gravis Association), and neurologist Lorenzo Maggi (Fondazione IRCCS Istituto Neurologico Carlo Besta di Milano) about the real burden of MG, the gaps in diagnosis and care, and what a more holistic, patient-centred future could look like. From lived experience to clinical expertise, this conversation makes the case for change, and explores how evidence-informed policy can transform care for people living with rare neuromuscular diseases in Europe.

What happens when a thriving performing arts career collides with a rare autoimmune disease? In this episode, I talk with Theresa Hill-Putnam about resilience, myasthenia gravis, positive thinking, and building an unstoppable mindset. Theresa owned a large performing arts school for 35 years before COVID and health risks forced her to pivot to virtual teaching. She shares how she was diagnosed after respiratory failure, how she learned to take life one day at a time, and why she believes in flipping the script when challenges hit. We also discuss empowerment coaching, motivational speaking, raising confident children, and her nonprofit, Performers with Purpose Foundation. Theresa's story proves that setbacks can become stepping stones when you choose growth, purpose, and persistence. I believe you will find this conversation both practical and inspiring. Highlights: 00:56 Learn how early dance training helped her overcome childhood shyness and build confidence. 05:03 Hear how a sudden health collapse led to a myasthenia gravis diagnosis. 12:33 Discover why taking one day at a time became her key to resilience. 20:05 Understand why she refused to quit despite being told to go on disability. 22:58 See how COVID forced a rapid shift to virtual teaching and musicals. 56:50 Learn how her nonprofit now provides thousands of Christmas gifts to children in need. Top of Form Bottom of Form About the Guest: After Owning and Directing a large performing Arts School for over 35 years, Teresa Hill-Putnam is now a Performance Coach & Empowerment CoachinLos Angeles, California. Teresa is also a published author, Motivational Speaker, and Special Events Coordinator. Teresa has been teaching since 1985. She now coaches singers, actors, dancers, and performers from all around the world. She helps artists master their skills, materials, and mindset. Teresa has helped hundreds of artists develop their talents, follow their dreams, and successfully pursue their career goal. In 1999, Teresa got very sick. In less than a week, she went from being able to dance and hold her leg above her head, to not being able to sit up, roll over, or even feed herself. She was in and out of the hospital for 18 months before she was finally diagnosed with a chronic neuro-muscular disease called Myasthenia Gravis. Teresa has learned to take one day at a time and make the most out of every day. Today, Teresa is happy and healthy. Most people do not even know that she has Myasthenia Gravis. Teresa believes that everyone has a story. She hopes to inspire others by sharing hers. Teresa has published eight books and has a podcast called "Overcoming Obstacles Through Positive Thinking." She has even been featured in in several documentaries. In 2018, Teresa helped to create non-profit called the Performers With Purpose Foundation. She directs performances year-round to help raise money for important community causes. Teresa's favorite project is the PWP annual “Sub for Santa” project. Each year, the Performers With Purpose Foundation provides gifts, toys, and clothing to underprivileged children during the holiday season. After years of being a single, working mom living with a chronic illness, Teresa understands how difficult the holiday season can be for struggling families. Being able to “adopt” families that need help brings Teresa an immense amount of joy! Teresa's most important accomplishment is being a Mom and a "Grammy." Teresa raised her own three children to become happy, healthy, and successful adults. Her oldest daughter owns a Performing Arts School in Denver and has two adorable little boys. Her son is in the United States Air Force and has two darling little boys and a beautiful baby girl. Teresa's youngest daughter, Amber Mackenzie, is a professional actor, singer, dancer and screenwriter. Teresa currently works as Amber's Performance Coach and Booking Manager. Teresa uses her experiences as a mother, "Grammy," teacher, patient, coach, and entrepreneur to help inspire, guide, challenge, motivate, support, and encourage others toward success. Ways to connect with Teresa**:** Teresa's website:  www.spotlightperformers.com Performers With Purpose Foundation website: www.performerswithpurposefoundation.com. Teresa's podcast,, can be found on Spotify, Apple Podcasts, You Tube, or your favorite streaming platform. https://youtube.com/playlist?list=PLAIx8SkZwXXPdNOkzPNHJZFwYne7yo3oG&si=d1yL7Sp4FNRLXdmS Facebook: https://www.facebook.com/teresa.hillputnam?mibextid=wwXIfr&mibextid=wwXIfr Instagram: https://www.instagram.com/teresahillputnam?igsh=eTJwazg1enRkb3N2&utm_source=qr LinkedIn: https://www.linkedin.com/in/teresa-hill-putnam-4bb92941?utm_source=share&utm_campaign=share_via&utm_content=profile&utm_medium=ios_app About the Host: Michael Hingson is a New York Times best-selling author, international lecturer, and Chief Vision Officer for accessiBe. Michael, blind since birth, survived the 9/11 attacks with the help of his guide dog Roselle. This story is the subject of his best-selling book, Thunder Dog. Michael gives over 100 presentations around the world each year speaking to influential groups such as Exxon Mobile, AT&T, Federal Express, Scripps College, Rutgers University, Children's Hospital, and the American Red Cross just to name a few. He is Ambassador for the National Braille Literacy Campaign for the National Federation of the Blind and also serves as Ambassador for the American Humane Association's 2012 Hero Dog Awards. https://michaelhingson.com https://www.facebook.com/michael.hingson.author.speaker/ https://twitter.com/mhingson https://www.youtube.com/user/mhingson https://www.linkedin.com/in/michaelhingson/ accessiBe Links https://accessibe.com/ https://www.youtube.com/c/accessiBe https://www.linkedin.com/company/accessibe/mycompany/ https://www.facebook.com/accessibe/ Thanks for listening! Thanks so much for listening to our podcast! If you enjoyed this episode and think that others could benefit from listening, please share it using the social media buttons on this page. Do you have some feedback or questions about this episode? Leave a comment in the section below! Subscribe to the podcast If you would like to get automatic updates of new podcast episodes, you can subscribe to the podcast on Apple Podcasts or Stitcher. You can subscribe in your favorite podcast app. You can also support our podcast through our tip jar https://tips.pinecast.com/jar/unstoppable-mindset . Leave us an Apple Podcasts review Ratings and reviews from our listeners are extremely valuable to us and greatly appreciated. They help our podcast rank higher on Apple Podcasts, which exposes our show to more awesome listeners like you. If you have a minute, please leave an honest review on Apple Podcasts. Transcription Notes:

What do you do when your own tongue starts "shedding" like a snake and your doctor tells you to just "eat a banana"? Imagine waking up and seeing the world through 90s TV static, while your muscles literally stretch and tear like gum when you yawn. Làyla joins the boys to break down the reality of living with Refractory Myasthenia Gravis (MG), a version of the illness so stubborn it requires constant infusions just to keep her stable. From the terrifying moment she realized her jaw was atrophying, to the bizarre neurological world of Visual Snow Syndrome, Làyla shares it all with a level of humor and confidence that is honestly infectious.You can watch this entire episode over on YouTube: https://www.youtube.com/playlist?list=PL0EVgIbBQOxtKJ4qjAlfeutzZRfCGV8nbFollow Sickboy: Instagram: https://www.instagram.com/sickboypodcastTiktok: https://www.tiktok.com/@sickboypodcastDiscord: https://discord.gg/expeUDN

What do you do when your own tongue starts "shedding" like a snake and your doctor tells you to just "eat a banana"? Imagine waking up and seeing the world through 90s TV static, while your muscles literally stretch and tear like gum when you yawn. Làyla joins the boys to break down the reality of living with Refractory Myasthenia Gravis (MG), a version of the illness so stubborn it requires constant infusions just to keep her stable. From the terrifying moment she realized her jaw was atrophying, to the bizarre neurological world of Visual Snow Syndrome, Làyla shares it all with a level of humor and confidence that is honestly infectious.You can watch this entire episode over on YouTube: https://www.youtube.com/playlist?list=PL0EVgIbBQOxtKJ4qjAlfeutzZRfCGV8nbFollow Sickboy: Instagram: https://www.instagram.com/sickboypodcastTiktok: https://www.tiktok.com/@sickboypodcastDiscord: https://discord.gg/expeUDN

In episode 99 of the Medical Nursing Podcast, join Zoe Hatfield (RVN, VTS in Neurology) and Laura Jones (RVN, VTS in Internal Medicine) as they discuss one of the most common neurological disorders seen in practice: Myasthenia gravis, or MG. MG is a disorder of the neuromuscular junction causing significant weakness, megaoesophagus, regurgitation, aspiration and recumbency - and these patients need INTENSIVE nursing care to recover.  We're breaking down exactly what MG is, how it impacts our patients, and the skills we can use when caring for them, in this episode. --- About Zoe: Zoe qualified as a registered veterinary nurse in 2012. After spending her first year as a RVN working in first opinion practice, she moved to referral joining the University of Glasgow Small Animal Hospital nursing team in 2013.  Since joining the nursing team, Zoe has developed her passion for neurology and in 2019 gained the VTS certificate in Neurology.  Working within the vet school she enjoys using her extensive experience in neurology to teach and educate students and newer members of staff.  She also presents CPD on a wide variety of neurological topics, including at BSAVA Alba, ExcelCPD, VetTrust, AIMVT and BVA Live. Watch Zoe's excelCPD webinar series here. --- More free ways to learn with me:

Recent medical news followed by a review of pathophysiology, clinical manifestations, diagnosis, and treatment of myasthenia gravis.News Articles:New federal vaccine schedule (KFF): https://www.kff.org/other-health/the-new-federal-vaccine-schedule-what-changed/HRT black box warning removal (FDA): https://www.fda.gov/news-events/press-announcements/hhs-advances-womens-health-removes-misleading-fda-warnings-hormone-replacement-therapyMore information about HRT warning label removal (Harvard Health): https://www.health.harvard.edu/womens-health/fda-removes-menopause-hormone-therapy-black-box-warningsHouse votes to extend ACA subsidies (PBS): https://www.pbs.org/newshour/politics/in-a-rebuke-of-gop-leadership-house-heads-toward-vote-to-extend-health-care-subsidiesReferences:Bird, S. J. Pathogenesis of myasthenia gravis. UpToDate. https://www.uptodate.com/contents/pathogenesis-of-myasthenia-gravisBird, S. J. Clinical manifestations of myasthenia gravis. UpToDate. https://www.uptodate.com/contents/clinical-manifestations-of-myasthenia-gravisBird, S. J. Diagnosis of myasthenia gravis. UpToDate. https://www.uptodate.com/contents/diagnosis-of-myasthenia-gravisBird, S. J. Overview of the treatment of myasthenia gravis. UpToDate. https://www.uptodate.com/contents/overview-of-the-treatment-of-myasthenia-gravis

To have Dr. Morse answer a question, visit: https://drmorses.tv/ask/   00:00:00 - Intro - New Teas! 00:15:48 - Weight - Hormones  00:32:34 - Diverticulitis 00:40:55 - Hyperthyroidism 00:47:50 - Bladder Cancer 00:54:58 - Lungs - Mucous - Breathlessness 01:13:43 - Myasthenia Gravis (MG) - Psoriasis - Afib (Atrial Fibrillation) 00:15:48 - Weight - Hormones  Is the extra weight holding back the flow of things? 00:32:34 - Diverticulitis I was told to have colorectal surgery to remove my entire large colon due to the bleeding. 00:40:55 - Hyperthyroidism The day after a vaccine, I started shedding my hair. 00:47:50 - Bladder Cancer Please tell me how I can rid my bladder of the chemo and restore the cells? 00:54:58 - Lungs - Mucous - Breathlessness Could you please talk about fasting one's way into a breatharian lifestyle? 01:13:43 - Myasthenia Gravis (MG) - Psoriasis - Afib (Atrial Fibrillation) I'm a MD from Mexico, living for a long time in the United States.

Sara Mariotto, MD, PhD - Beyond Myasthenia Gravis: What Are We Learning About FcRn Inhibitors in Other Rare Neuroimmunological Disorders?

Sara Mariotto, MD, PhD - Beyond Myasthenia Gravis: What Are We Learning About FcRn Inhibitors in Other Rare Neuroimmunological Disorders?

Sara Mariotto, MD, PhD - Beyond Myasthenia Gravis: What Are We Learning About FcRn Inhibitors in Other Rare Neuroimmunological Disorders?

Sara Mariotto, MD, PhD - Beyond Myasthenia Gravis: What Are We Learning About FcRn Inhibitors in Other Rare Neuroimmunological Disorders?

Sara Mariotto, MD, PhD - Beyond Myasthenia Gravis: What Are We Learning About FcRn Inhibitors in Other Rare Neuroimmunological Disorders?

Sara Mariotto, MD, PhD - Beyond Myasthenia Gravis: What Are We Learning About FcRn Inhibitors in Other Rare Neuroimmunological Disorders?

CME credits: 0.25 Valid until: 31-12-2026 Claim your CME credit at https://reachmd.com/programs/cme/diagnostic-and-diagnosis-logistics-navigating-complexity-across-ages/39028/ Drs. Jonathan Strober and Diana Castro examine the diagnostic approach to generalized myasthenia gravis (gMG), with a focus on age-related differences in clinical presentation. They describe early signs in pediatric patients—such as ptosis and impaired extraocular movements—and contrast these with the fluctuating fatigue, bulbar involvement, and proximal muscle weakness more commonly seen in adults. The discussion includes practical strategies for diagnostic confirmation and highlights the role of antibody testing and the limitations of electrophysiologic studies in children. The faculty emphasize the importance of keeping MG in the differential diagnosis to minimize delays in recognition and treatment.=

CME credits: 0.25 Valid until: 31-12-2026 Claim your CME credit at https://reachmd.com/programs/cme/mg-therapeutic-selection-and-monitoring-efficacy-matching-mechanisms-to-patients/39030/ Drs. Diana Castro and Jonathan Strober discuss treatment strategies for generalized myasthenia gravis (gMG), focusing on pediatric and adolescent care. They review traditional therapies and newer agents, such as FcRn and complement inhibitors, highlighting the role of antibody status and considerations for thymectomy. The conversation also addresses monitoring challenges, including limitations of clinical scales and the importance of patient and caregiver input in assessing treatment response.=

CME credits: 0.25 Valid until: 31-12-2026 Claim your CME credit at https://reachmd.com/programs/cme/gmg-patient-stratification-and-antibody-profiling-personalizing-the-disease-lens/39029/ This discussion between Drs. Diana Castro and Jonathan Strober focuses on the clinical utility of patient stratification and antibody profiling in generalized myasthenia gravis (gMG). The conversation addresses how age of onset, antibody status (acetylcholine receptor, MuSK, LRP4), and comorbidities can influence diagnosis and management plans. The speakers highlight the limitations of current pediatric assessment tools and the implications of antibody status for access to targeted therapies. Practical considerations for repeat testing, use of modified clinical scales, and individualized communication strategies with pediatric patients and families are also examined, emphasizing the nuanced approach required in younger populations.=

Neumeier, Claudia www.deutschlandfunk.de, Sprechstunde

In this episode of the Brain and Life podcast, co-host Dr. Katy Peters is joined by tennis legend Monica Seles. They discuss Monica's iconic career, the life lessons she learned from tennis, her experience with Myasthenia Gravis, and the importance of advocacy for health awareness. Dr. Peters is then joined by Dr. Andrea Markl Corse, Professor of Neurology and Director of the Myasthenia Gravis Clinic at The University of North Carolina School of Medicine. Dr. Corse explains what Myasthenia Gravis is and why advocacy makes a difference.   Additional Resources Physical Activity Helps Manage Myasthenia Gravis Myasthenia Gravis Foundation of America What is Myasthenia Gravis?   Other Brain & Life Podcast Episodes on These Topics Recovery Through Rhythm: Jazz Musician John Stein's Myasthenia Gravis Journey Ashley Brooks on Advocating for Herself and Others with Myasthenia Gravis Soap Opera Star Suzanne Rogers Brings Awareness to Myasthenia Gravis     We want to hear from you! Have a question or want to hear a topic featured on the Brain & Life Podcast? ·       Record a voicemail at 612-928-6206 ·       Email us at BLpodcast@brainandlife.org   Social Media:   Guest: Monica Seles @monicaseles10s; Dr. Andrea Corse @unc_neurology Hosts: Dr. Daniel Correa @neurodrcorrea; Dr. Katy Peters @KatyPetersMDPhD

CME credits: 0.50 Valid until: 15-12-2026 Claim your CME credit at https://reachmd.com/programs/cme/implementing-the-latest-diagnostic-and-treatment-approaches-for-generalized-myasthenia-gravis/32961/ In this expert commentary, Dr. Narayanaswami highlights key messages from the Prova Education satellite symposium held at the 2025 AANEM Meeting in San Francisco. The discussion centers on the clinical application of FcRn antagonists in gMG, reviewing the rationale for FcRn blockade, approved FcRN antagonists, and pivotal clinical trial data. Differences in therapy onset, duration, administration, and tolerability are outlined, along with considerations for treatment selection based on antibody profiles and diagnostic criteria. Practical insights address use in special populations, coordination with plasma exchange, and vaccination timing, offering clinicians a concise synthesis of the symposium's clinical guidance.=

Klinisch Relevant ist Dein Wissenspartner für das Gesundheitswesen. Drei mal pro Woche, nämlich dienstags, donnerstags und samstags, versorgen wir Dich mit unserem Podcast und liefern Dir Fachwissen für Deine klinische Praxis. Weitere Infos findest Du unter https://klinisch-relevant.de

This activity was supported by an educational grant from argenx. Credit is available through May 4, 2026.

Dr. Aaron Zelikovich discusses a recent article on nipocalimab and its role in treating generalized myasthenia gravis.  Show citations:  Antozzi C, Vu T, Ramchandren S, et al. Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study. Lancet Neurol. 2025;24(2):105-116. doi:10.1016/S1474-4422(24)00498-8

This activity was supported by an educational grant from Vor Bio. Please go to⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ http://academiccme.com/MG-AANEM-25 and complete the evaluation to receive your CE/CME Credit. Credit is available through November 4, 2026.

In this special international episode, we explore the 2025 update of the Association of British Neurologists' guidelines on managing autoimmune myasthenia gravis. Ten years after the previous recommendations, significant changes have been introduced. We emphasise the importance of daily steroids, early thymectomy, rituximab, and emerging targeted therapies transforming patient care. We also examine how these updates influence frontline care in the UK, Australia, and the USA, and why a multidisciplinary approach remains vital in the management of MG.   Participants: Professor Alasdair Coles is Head of Department for Clinical Neuroscience and also Co-Director of the Cambridge Centre for Myelin Repair, UK. Associate Professor Katherine Buzzard, Clinical Lead, Eastern Health Multiple Sclerosis and Neuroimmunology Service, Melbourne, Australia. Dr. Christopher Doughty, MD is a board-certified neurologist, and affiliated with Brigham and Women's Hospital, in Boston, Massachusetts, USA. Read the paper (https://pn.bmj.com/content/25/5/422), which is part of the October issue of the Practical Neurology journal.   Please subscribe to the Practical Neurology podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3vVPClm) or Spotify (https://spoti.fi/4baxjsQ). We'd love to hear your feedback on social media - @PracticalNeurol. Production and editing by Letícia Amorim. Thank you for listening. 

In this AANEM session, Chilvana Patel, MD moderates a discussion with Pushpa Narayanswami, MD, Nicholas Silvestri, MD, and Kelly Gwathmey, MD on the evolving treatment landscape in myasthenia gravis (MG). The panel reviews the use of targeted therapies in women of childbearing age with myasthenia gravis, alongside guidance for perioperative care before elective surgery. Through illustrative patient cases, the experts provide insight into practical challenges and emerging opportunities in tailoring advanced immunotherapies to individual patient needs.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Novartis and Monte Rosa have entered into their second molecular glue deal worth up to $5.7 billion, with Novartis putting $120 million upfront for more of the biotech's AI-discovered degraders. The myasthenia gravis market, once sparse, is now flourishing with new treatments approved and promising late-stage trial results from companies like Argenx and Regeneron. In other news, AstraZeneca has suspended its $270 million commitment in the UK, the FDA has flip-flopped on scrapping advisory committee meetings, and Sino Biological has developed a high-throughput platform for AI-driven antibody discovery. The myasthenia gravis space is heating up with targeted therapies, with several companies releasing promising late-stage trial results. Biogen is developing a pipeline for lupus, with investors showing interest in their programs. The FDA has several actions scheduled for September, including Merck's proposed subcutaneous formulation of Keytruda. Eli Lilly's obesity pill, Orforglipron, is in focus at the European Association for the Study of Diabetes meeting. In the cancer news, Merck's Keytruda challenger faces consistency problems, while other companies like Daiichi Sankyo and Biontech report positive data. Capsida reports a patient death in a gene therapy trial, while Alkermes shows promise in narcolepsy treatment. FDA is looking to streamline the development of non-opioid painkillers. Various webinars and events are upcoming in the pharma industry. Job opportunities are available at companies like Moderna, Abbvie, and Regeneron. Overall, the biopharma industry is seeing advancements and progress in various therapeutic areas.

About 1-in-6 Americans suffer from an Autoimmune Disease, which is actually a growing problem.  In this episode, we talk about:—How Dr. Prather's career was inspired by his own battle with Graves' Disease, which is an Autoimmune Disease.  And why making sure the Atlas is in proper place is "critical" for Autoimmune Disease and needs to be corrected first before there can be any progress.—The various categories of Autoimmune Disease:  Joints and Muscles (Rheumatoid Arthritis, Lupus, Myositis), Skin and Blood Vessels (Sjogren's Syndrome, Psoriatic Arthritis, Vitiligo), Digestive (Celiac Disease, Crohn's Disease, Ulcerative Colitis), the Endocrine System (Type I Diabetes, Addison's Disease, Hashimoto's, Thyroiditis, Graves' Disease), the Nervous System (Multiple Sclerosis, Myasthenia Gravis, Guillain-Barre), the Lymphatic System (Fibromyalgia), and many more.—The different infections that can kick off Autoimmune Disease, including Viruses, Bacteria, Parasitic, or Fungal.   And how Heavy Metal Toxicities and Stress can cause of Autoimmune Disease.—Why the underlying cause of the Autoimmune Disease is more important to determine in Dr. Prather's Structure-Function Health Care model, while the Disease Care approach focuses on managing and suppressing the symptoms.  And the "huge" role that the Gut plays in Autoimmune Diseases.—The new cutting-edge area of drugs called Biologics and how they work.  And how Vaccines are actually classified as Biologics.—How Immunosuppressant Drugs can be helpful and life-saving, but can also increase your chances of Cancer and a shortened life-span.  And why Dr. Prather says, "The more drugs that you take, the longer you take them, the more likely you are to have an issue."—Why your ability to fight infections, viruses, fungal, and parasites "go way down" if you are taking an Immunosuppressant Drug.—How Dr. Prather himself and many of his patients are a "testament" that Medical Doctors are wrong when taught to believe that there is no hope of getting well from Autoimmune Disease.  And how the Structure-Function Care results he sees in his office disprove the Medical model's belief that symptoms should just be managed and that the patient will always get worse.—Why Dr. Prather says "we're not going to get anywhere" with an Autoimmune Disease if you have Heavy Metal toxicity.  And the importance of thorough diagnostics in Structure-Function Care to determine the root cause of the Autoimmune Disease that needs to be corrected.—The effectiveness of Structure-Function Care, which is "the only way you're going to make headway in an Autoimmune Disease".  And the reason Homeopathics are described by Dr. Prather as "a real key" for making dramatic changes in Autoimmune Disease.http://www.TheVoiceOfHealthRadio.com

Early and accurate diagnosis is essential for obtaining a good clinical outcome for veterinary patients with acquired myasthenia gravis. Tune in to this episode of the VetFolio Voice podcast to learn how it's diagnosed and what treatment options are available. Host Dr. Cassi and guest Dr. Lauren Downey Koos also engage in a bigger conversation regarding neuromuscular disease.

This program is supported by an educational grant from UCB, Inc. This accredited CME program highlights the latest clinical research about myasthenia gravis, a rare, autoimmune disease that targets the neuromuscular junction.  This program, led by Dr. James Howard Jr, provides a summary of clinically relevant data presented at the American Academy of Neurology Annual Meeting (AAN 2025) held in San Diego, CA that can enhance the care of patients with myasthenia gravis.  To obtain CME credit for this program, visit https://checkrare.com/learning/p-myasthenia-gravis-clinical-research-highlights-aan-2025/Target AudienceThis activity has been designed to meet the educational needs of physicians specializing in neurology, ophthalmology, rheumatology, and family practice. Other members of the care team may also participate.Learning ObjectivesAfter participating in the activity, learners should be better able to:Describe the latest research being presented to better manage individuals with myasthenia gravis and its clinical relevance.FACULTY James F. Howard Jr, MD, FAANProfessor of NeurologyUniversity of North Carolina at Chapel HillDisclosure StatementAccording to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated.Disclosure of relevant financial relationships are as follows:Faculty Educator/PlannerDr. Howard discloses the following relevant financial relationships with ineligible companies:Advisory Board/Consultant: Alexion AstraZeneca Rare Disease, Amgen, argenx, Biohaven Ltd, Cartesian Therapeutics, CoreEvitas, Curie.bio, Hansa Biopharma, H. Lundbeck A/S, Merck EMD Serono, NMD Pharma, Novartis Pharma, Regeneron Pharmaceuticals, Sanofi US, Seismic Therapeutics, TG Therapeutics, Toleranzia AB, and UCB PharmaGrant/Research Support: Ad Scientiam, Alexion AstraZeneca Rare Disease, argenx, Cartesian Therapeutics, NMD Pharma, and UCB PharmaOther Relationships: non-financial support (eg travel) Alexion AstraZeneca Rare Disease, argenx, Biohaven Ltd, Cartesian Therapeutics, Toleranzia AB, and UCB Pharma.Other Planners for this activity have no relevant financial relationships with any ineligible companies.This activity will review off-label or investigational information.The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy or CheckRare CE. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.CREDIT Accreditation and Credit DesignationIn support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and CheckRare CE. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.PhysiciansAmerican Academy of CME, Inc., designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Other HCPsOther members of the care team will receive a certificate of participation.There are no fees to participate in the activity.  Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME credit for your participation, please complete the pre and post-program assessments. Your certificate will be emailed to you within 30 days.PrivacyFor more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm  For more information about CheckRare's privacy policy, please access https://checkrare.com/privacy/ContactFor any questions, please contact: CEServices@academycme.orgCopyright© 2025. This CME-certified activity is held as copyrighted © by American Academy of CME and CheckRare CE. Through this notice, the Academy and CheckRare CE grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

Chilvana Patel, MD is hosting a case-based panel discussion titled "Evolving Therapeutic Horizons in Myasthenia Gravis: Expert Perspectives on Targeted Therapies - Part 1." She will engage with renowned neuromuscular specialists—Pushpa Narayanaswami, MD, Nicholas Silvestri, MD, and Kelly Gwathmey, MD—to explore real-world cases and discuss the latest advances in targeted treatment options for Myasthenia Gravis.

Today we'll focus on a major shift in the treatment of myasthenia gravis -- as a wave of new therapies is changing how we treat this disease. Who should be considered for these new treatments? And what else is in the pipeline?   Our guest today is Dr.  Gil Wolfe, a neuromuscular neurologist at the University of Buffalo State University of New York, Jacob School of Medicine and Biomedical Sciences. Dr. Wolfe was interviewed by Dr. Ioannis Karakis, adjunct professor of neurology at Emory University School of Medicine.   References: https://www.nature.com/articles/s41598-024-79918-7   Disclosures: Dr. Wolfe discloses: Consultant for: Alexion, Argenx, BPL, Cartesian, Canopy, Grifols, Johnson & Johnson, Takeda, UCB; Speaker Bureau for: Grifols, Alexion, UCB; Grant/Research support from: ArgenX, Ra/UCB, Immunovant, Roche, Alexion, Sanofi

In this inspiring episode, we sit down with Dr. Don Shields, a true icon in veterinary medicine whose compassion, innovation, and work ethic continue to shine at age 88. With a career spanning more than six decades, Dr. Shields shares his remarkable journey from founding Bethayers Veterinary Hospital in 1964 to still practicing today, focusing on end-of-life care.You'll hear firsthand about his pioneering work with pacemakers in dogs (as early as 1974!), his travels to Switzerland to study innovative orthopedic techniques, and his contributions to the field through writing and mentorship. Whether caring for Bradley Cooper's dog or co-authoring a piece on Myasthenia Gravis for Scientific American, Dr. Shields has always been ahead of the curve.This episode highlights not only his clinical accomplishments but also his passion for feral cat welfare, along with his wife, Donna, his enduring athletic spirit (30+ RAGBRAI rides, skiing, tennis, and sailing!), and his belief that general practitioners were once the heart of a “golden era of veterinary medicine.”What You'll Learn:What veterinary medicine looked like in the 1960s and how it's evolvedThe story behind two dogs with pacemakers - truly groundbreaking in the 1970-80sHow human orthopedic techniques influenced animal surgeryWhy Dr. Shields still chooses to work at 88—and the cases he's proudest ofThe joys and challenges of a life devoted to animalsClick here to learn about an organization called ReGen that collects and refurbishes donated human pacemakers for placement in animals.DisclaimerVitalVet.org, a platform for all things related to pet rehab - product information, education, and resources abound! MedcoVet (show sponsor) Luma - advanced red-light therapy therapy that puts healing in the hands of the pet owner in the comfort of home! Use Promo Code PETPOD22, to receive discounts from our affiliates! Ruff Ramp - a safe alternative to stairs. You receive 10% off and PetAbility receives 10%.Dr. Buzby's - The Senior Dog Company – Toe grips to prevent slipping, Encore Mobility joint supplement, and Brain Boost cognitive supplement. You receive 10% off and PetAbility receives 10% from your first order.Extra love – use this link and the entire 20% goes to support our show! Calm & Cozy Cat Wrap - a must-have for cat owners and vet pros working with cats! Use PETPOD22 for $5 off your order.HedzUpPets Watercollars – save your dog from drowning around any body of water...

Episode Summary: In this episode, Dr. Vickie Petz Kasper shares her powerful story of how a rare neuromuscular disorder abruptly ended her 20-year career as an OB/GYN, transforming her life in an instant. From delivering thousands of babies to becoming a patient herself, Vickie opens up about the pain of losing her identity as a doctor and battling bitterness. Yet, in the midst of her struggle, she discovered the faithfulness of God, who used her season of forced rest to bring healing, comfort, and purpose. Through scripture, gratitude, and a shift in focus, Vickie learned how to trust God, reclaim her identity in Christ, and ultimately use her experience to offer hope and comfort to others facing their own trials. Quotables from the episode: What I have found is that if we will allow God to, he will take our deepest areas of pain and discomfort and ultimately use it for our good. I was an OB /GYN doctor, delivered 5,000 babies during my career. And that was such a treasure, such a privilege to be there at that special moment at the beginning of life, to be the first person to hold a newborn baby. So, I was in the operating room doing a C-section when all of a sudden, my hands refused to obey my brain. And I kept staring at them, expecting them to move, and they were just still. Now, I say suddenly, in reality, about six weeks before, I had been diagnosed with a disease called myasthenia gravis, but it initially only affected my eyes. So, we knew what was happening, and I was having some subtle symptoms, but I was preparing for a 57-mile bicycle ride across the state of Missouri the next day. I was kind of ignoring some symptoms. So, when I say suddenly, I don't really mean suddenly, but it felt suddenly. I went from being a surgeon in the operating room to being a patient in the emergency room in an instant. It was a very painful season from the outset because not only did, in an instant, I lose my career, my ability to ride my bicycle, and all the other active things that I loved about my life, but I also felt betrayed by my own profession. I think the beginning of a wound that was the most difficult to heal from, that I had to fight was a root of bitterness. When the Bible talks about a root of bitterness, you just think about weeds in your yard or your flower garden or whatever. If you don't pull up that whole entire root, there are little tentacles that go deep down inside. And I just felt like I was feeding the root of bitterness. I was rehearsing all the things I wanted to say or wish I would have said. I was rehearsing you know, "Oh, wasn't this horrible what happened to me?" I was angry, and I was nurturing that root of bitterness. And I knew that if I didn't deal with it, it would absolutely destroy me. I had to shift my mindset. I had to shift my focus. I had to put my eyes on the Lord. I already had done a lot of Bible study and had a good foundation of the Word of God. It was so cool how God would bring a scripture through a card that I got in the mail or through a phone call that I got or what I had read that morning. And then he would just affirm and reaffirm that all day long. That assured me of his presence, but it was being in his word in advance and shifting my mindset to a focus of what I had rather than what had happened to me. I would get up in the mornings and I would just go outside with the stars still out and I would literally count my blessings, just focusing on some gratitude. I was always a person that liked to write in journal. So, I started writing out my struggle through a blog and then eventually a little small book about forgiveness. I always say it's not a book to read, it's a book to do. I have to reread it myself because I went through additional things after that. After that, my 30 -year marriage ended, and so I had to sort of practice what I preached. When I lost my career as an OB/Gyn, that became an identity issue because when you’re a physician, you’re Dr. So-and-so, and it becomes so much a part of your identity. I caution not to let our identity be in anything that can be lost. If our identity is not in Christ which is permanent anchor for our soul and our only hope that never shifts the foundation that is firm, then anything that can be lost, we can lose ourselves whether it’s being a mom or being a wife or any of those things. I had to make sure that my identity was secure in Christ. Our occupation is what “we do,” it’s not “who I am.” God gave me comfort to know that God would use my situation to comfort others. We're all going to go through some kind of wounding. We don't get to choose what that experience is, but God says, “in this world you will have trouble.” But if we will allow God to come in and heal it, he can redeem it, he can heal, he can restore. It's been about a decade now since all of that happened. So in so many ways, I think through blogging and connecting with other believers, that was part of my own healing. It was, you know, I'm writing for other people, but I'm writing for me. Then I also connected with a lot of other people who have Myasthenia Gravis. I have spoken at national meetings for Myasthenia Gravis and talked to other people because it's a hopeless, frustrating disease that steals everything you love about your life. That was an area of redemption to be able to go and share with others the hope that I've received, the comfort that I've received, like 2 Corinthians 11:11 says, continuing on in the word. God took my background as an OB -GYN doctor for 20 years. I spent about seven years in the hospital administration learning about leadership. Then I got remarried and I got board certified in lifestyle medicine. Lifestyle Medicine had personally helped me and now I have a telehealth practice and my own podcast where I talk about Lifestyle Medicine and I just see these threads that God has pulled in and woven together to say, “because of these experiences you are qualified to do something new” and I love it. God spoke to me through His word and that's His language. That's how He speaks. If you want to speak to someone who only speaks French, you have to learn French. If you want to hear from the Lord, you need to know his language and his language is his word. I think having those index cards, having some scripture memorized, having some scripture hidden in my heart as the Bible says, that showed me that your God is faithful, and you can trust him no matter what? There's no need to be bitter and vengeful and to nurse a wound and nurse unforgiveness because that will destroy you. God tells us to cast our cares on him. You have to give your burdens to the Lord. So practically walking out, not just what was in my Bible, but what was written on those index cards. And I think it’s even a step beyond that. I think that it is one thing to write it, but then we have to go beyond that. We have to rehearse it. We've got to be speaking his word out. We've got to take it from head knowledge to heart knowledge. I would really encourage your listeners, if you're not going through a hard time right now, now's the time to prepare for the battle. Because like you said, it will come. Life comes in seasons. I'm in a good season right now. I was in a good season 10 years ago before all this started, but I had that foundation of the word. I think it all comes down to trust, really. You can know the word, rehearse the word, and what that helps you do is understand the absolute faithfulness and character of God. And that's what you build your life on in the good times and the bad. And when we look at the character of God, what is so comforting to me is that he is the same yesterday, today, that he will be tomorrow. He is unchanging. We're going to make mistakes, but God is never changing. So, the same God that was faithful to divide the Red Sea is going to be the same God that's going to find a path through our wilderness season, through our full trials to get us to the other side. But to your point, are we going to trust him through it? Or are we going to be angry and vengeful and bitter? It's a choice. God tells us to rest in him. And I think, you know, he set that model for us in creation in that seventh day he rested, and I don't think that was because he was tired, or he needed rest. I think it was because he was satisfied, and I think he wants us to come to him and say you're enough Lord and he wants us to rest in him. He says, “come to me all you who are weary and heavy burdened and I'll give you rest.” For me that looks like trust like rest from your striving to fix everything and to control the script so that it goes the way you want it to go. Rest in the Lord that his plans and purposes for your life are good. God is faithful and he can always be trusted. Scripture References: Psalm 55:22 NIV “Cast your cares on the LORD and he will sustain you; he will never let the righteous be shaken.” John 16:33 NIV “I have told you these things, so that in me you may have peace. In this world you will have trouble. But take heart! I have overcome the world.” 2 Corinthians 1:4 NIV “…who comforts us in all our troubles, so that we can comfort those in any trouble with the comfort we ourselves receive from God.” Recommended Resources: Sacred Scars: Resting in God’s Promise That Your Past Is Not Wasted by Dr. Michelle Bengtson The Hem of His Garment: Reaching Out To God When Pain Overwhelms by Dr. Michelle Bengtson, winner AWSA 2024 Golden Scroll Christian Living Book of the Year and the 2024 Christian Literary Awards Reader’s Choice Award in the Christian Living and Non-Fiction categories YouVersion 5-Day Devotional Reaching Out To God When Pain Overwhelms Today is Going to be a Good Day: 90 Promises from God to Start Your Day Off Right by Dr. Michelle Bengtson, AWSA Member of the Year, winner of the AWSA 2023 Inspirational Gift Book of the Year Award, the 2024 Christian Literary Awards Reader’s Choice Award in the Devotional category, the 2023 Christian Literary Awards Reader’s Choice Award in four categories, and the Christian Literary Awards Henri Award for Devotionals YouVersion Devotional, Today is Going to be a Good Day version 1 YouVersion Devotional, Today is Going to be a Good Day version 2 Revive & Thrive Women’s Online Conference Revive & Thrive Summit 2 Trusting God through Cancer Summit 1 Trusting God through Cancer Summit 2 Breaking Anxiety’s Grip: How to Reclaim the Peace God Promises by Dr. Michelle Bengtson, winner of the AWSA 2020 Best Christian Living Book First Place, the first place winner for the Best Christian Living Book, the 2020 Carolina Christian Writer’s Conference Contest winner for nonfiction, and winner of the 2021 Christian Literary Award’s Reader’s Choice Award in all four categories for which it was nominated (Non-Fiction Victorious Living, Christian Living Day By Day, Inspirational Breaking Free and Testimonial Justified by Grace categories.) YouVersion Bible Reading Plan for Breaking Anxiety’s Grip Breaking Anxiety’s Grip Free Study Guide Free PDF Resource: How to Fight Fearful/Anxious Thoughts and Win Hope Prevails: Insights from a Doctor’s Personal Journey Through Depression by Dr. Michelle Bengtson, winner of the Christian Literary Award Henri and Reader’s Choice Award Hope Prevails Bible Study by Dr. Michelle Bengtson, winner of the Christian Literary Award Reader’s Choice Award Free Webinar: Help for When You’re Feeling Blue Social Media Links for Host and Guest: Connect with Dr. Vickie Petz Kasper: Podcast / Instagram / LinkedIn / Facebook / YouTube / Pinterest For more hope, stay connected with Dr. Bengtson at: Order Book Sacred Scars / Order Book The Hem of His Garment / Order Book Today is Going to be a Good Day / Order Book Breaking Anxiety’s Grip / Order Book Hope Prevails / Website / Blog / Facebook / Twitter (@DrMBengtson) / LinkedIn / Instagram / Pinterest / YouTube / Podcast on Apple Guest: Vickie Petz Kasper, M.D. practiced ob/gyn for 20 years until she landed on the other side of the sheets. A rare neuromuscular disorder turned her life upside down. But God used a season of forced rest to show His faithfulness. Hosted By: Dr. Michelle Bengtson Audio Technical Support: Bryce Bengtson Discover more Christian podcasts at lifeaudio.com and inquire about advertising opportunities at lifeaudio.com/contact-us.

Whew! Celebrate with me and catch up!

What does it actually look like to go through a mold remediation—start to finish? In this episode of Never Been Sicker, Michael sits down with Kathleen LeGrys, a HomeCleanse client, to share her firsthand experience navigating chronic illness, discovering hidden mold in her home, and going through the full inspection and remediation process with HomeCleanse.After struggling for years with Lyme, Bartonella, and Myasthenia Gravis, Kathleen was still not improving as expected. Eventually, high mycotoxin levels led her functional medicine doctor to suspect mold exposure—and that kicked off a journey most people never expect to take.Kathleen walks us through:- The early overwhelm of discovering mold and deciding where to start- Why she chose to remediate her home in phases (and how she budgeted for it)- What she did before remediation to reduce exposure (including air purifiers and open windows)- How her lab markers improved just from lowering dust and airborne toxins- What she replaced in her home—and how she tested items like bedding and furniture to decide what to toss- The emotional, physical, and financial toll of the process—and why she has zero regretsIf you've ever felt overwhelmed by mold, toxins, or chronic symptoms—this is a must-listen success story.00:00 Introduction to Mold and Health Challenges02:50 Kathleen's Journey with Mold and Health06:00 Testing for Mold: Dust Tests vs. Mold Dogs09:11 Understanding Mycotoxins and Health Correlation11:45 The Cost of Mold Inspection and Remediation14:50 Mental Challenges in Addressing Mold Issues17:54 The Remediation Process: Logistics and Challenges21:08 Post-Remediation: Rebuilding and Testing23:58 Living with Mold: Interim Solutions27:06 The Importance of Replacing Contaminated Items30:00 Addressing Misconceptions About Mold33:56 Historical Perspectives on Mold Remediation35:51 Insurance Challenges and Mold Coverage37:32 Societal Perceptions of Mold and Health39:58 Understanding Mold Exposure and Symptoms46:12 The Prevalence of Mold in Homes49:57 Personal Experiences with Mold Remediation54:46 Advice for Those Facing Mold Issues

Please visit answersincme.com/ABT860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in neurology discusses the clinical evidence for novel complement (C5) inhibitors in the treatment of generalized myasthenia gravis (gMG) and personalized multidisciplinary management strategies. Upon completion of this activity, participants should be better able to: Review the rationale for novel C5 inhibitors in the treatment of generalized myasthenia gravis (gMG); Describe the long-term clinical data of C5 inhibitors for the treatment of gMG; and Discuss strategies to personalize multidisciplinary management plans for patients with gMG.

Please visit answersincme.com/ABT860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in neurology discusses the clinical evidence for novel complement (C5) inhibitors in the treatment of generalized myasthenia gravis (gMG) and personalized multidisciplinary management strategies. Upon completion of this activity, participants should be better able to: Review the rationale for novel C5 inhibitors in the treatment of generalized myasthenia gravis (gMG); Describe the long-term clinical data of C5 inhibitors for the treatment of gMG; and Discuss strategies to personalize multidisciplinary management plans for patients with gMG.

Dr. Aaron Zelikovich discusses a phase 3 trial that looked at the use of inebilizumab in generalized myasthenia gravis.  Show reference:  https://www.nejm.org/doi/full/10.1056/NEJMoa2501561

In this episode, Sam Ashoo, MD and T.R. Eckler, MD discuss the May 2025 Emergency Medicine Practice article, Emergency Department Management of Patients With Complications of Chronic Neurologic Disease: Parkinson Disease, Myasthenia Gravis, and Multiple Sclerosis Parkinson's DiseaseImportance of maintaining medication schedule for Parkinson's patients Strategies for ensuring patients receive their medications promptly Overview of Carbidopa Levodopa's mechanism of actionMyasthenia GravisDescription of the disease mechanism Importance of assessing respiratory function Diagnostic alternatives like the negative inspiratory force test and counting test Discussion on appropriate emergency department actions and treatments including steroids, plasmapheresis, and IVIGMultiple SclerosisDescription of the disease mechanism Description of the typical patient demographic Discussion on the varied presentation of MS Treatment strategies including high-dose steroids and BaclofenEmergency Medicine Residents, get your free subscription by writing resident@ebmedicine.net 

In today's VETgirl online veterinary continuing education podcast, we interview Dr. Missy Carpentier, DACVIM (Neurology) of Minnesota Veterinary Neurology on myasthenia gravis in dogs and cats. What exactly is myasthenia gravis, and what's the classic presentation in dogs and cats? Tune in to learn how we diagnose it, what the typical signalment is, and most importantly, how to treat myasthenia gravis!

In today's VETgirl online veterinary continuing education podcast, we interview Dr. Missy Carpentier, DACVIM (Neurology) of Minnesota Veterinary Neurology on myasthenia gravis in dogs and cats. What exactly is myasthenia gravis, and what's the classic presentation in dogs and cats? Tune in to learn how we diagnose it, what the typical signalment is, and most importantly, how to treat myasthenia gravis!

The May 2025 recall features four previously posted episodes on myasthenia gravis. The first episode has Dr. Fredrik Piehl discussing rituximab for new-onset generalized MG. In the second episode, Dr. Vera Bril explores the potential use of immunoglobulin as a corticosteroid-sparing agent in MG patients. The third episode features Dr. Ali A. Habib discussing trends in hospital admissions and in-hospital mortality for adult MG patients. The series concludes with Dr. Jennifer Morganroth addressing the increase in thymectomy procedures post-MGTX trial, disparities in access to these surgeries among different demographic groups, and the rise of minimally invasive surgical techniques. Podcast links: Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis  Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis Hospitalizations and Mortality from MG Hospitalizations and Mortality From Myasthenia Gravis Trends and Disparities in the Utilization of Thymectomy for MG in the US Article links: Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis Hospitalizations and Mortality From Myasthenia Gravis Trends and Disparities in the Utilization of Thymectomy for Myasthenia Gravis in the United States Disclosures can be found at Neurology.org.

Biopharma companies are vying to dethrone Vyvgart as a leading therapy for myasthenia gravis, with the latest data for therapies treating the rare autoimmune neuromuscular disease coming at this month's American Academy of Neurology. On a special episode of the BioCentury This Week podcast, BioCentury's editors discuss the landscape for MG therapies, including anti-BLyS and APRIL therapy telitacicept from Remegen. Joining BioCentury's editors are Qing Zuraw, chief development officer of podcast sponsor RemeGen, and Amit Sachdev, PI on global trials of the biotech's therapy. BioCentury's editors also preview the American Association for Cancer Research annual meeting, where degraders and bispecifics are defining translational trends at this year's event. This episode of BioCentury This Week podcast was sponsored by RemeGen.View full story: https://www.biocentury.com/article/655751#biotech #biopharma #pharma #lifescience #AAN #AACR00:01 - Sponsor Message: RemeGen Co.01:02 - Myasthenia Gravis at AAN08:31 - RemeGen's Telitacicept18:03 - AACR: Targets and TrendsTo submit a question to BioCentury's editors, email the BioCentury This Week team at podcasts@biocentury.com.Reach us by sending a text

A 70-year-old client fills in an online intake form, saying she has myasthenia gravis, hypertension, and hypothyroidism. She only takes Synthroid, and says her hypothyroidism and hypertension are well controlled. She has low back pain and muscle soreness. At first glance, this seems fairly simple. MG does not appear to be a major factor for her, because she is not controlling it with medication. But a closer look reveals some possible tangles between MG, hypothyroidism, and some cautions about hypertension drugs. Join me as I completely overthink this situation, it will be fun!   Resources:   Barnes, S. (2023) Massage is not just a luxury for those of us with myasthenia gravis | Myasthenia Gravis News. Available at: https://myastheniagravisnews.com/columns/massage-is-not-just-luxury-those-us-with-myasthenia-gravis/ (Accessed: 16 April 2025).   Myasthenia Gravis (no date a) Physiopedia. Available at: https://www.physio-pedia.com/Myasthenia_Gravis (Accessed: 16 April 2025).   Myasthenia Gravis (no date b). National Library of Medicine. Available at: https://medlineplus.gov/myastheniagravis.html (Accessed: 16 April 2025).   Myasthenia Gravis | National Institute of Neurological Disorders and Stroke (no date). Available at: https://www.ninds.nih.gov/health-information/disorders/myasthenia-gravis (Accessed: 16 April 2025).   Myasthenia gravis - causes, symptoms, treatment, pathology (2016). Available at: https://www.youtube.com/watch?v=bYGxGdu9MsQ (Accessed: 16 April 2025).   ‘Myasthenia Gravis: Practice Essentials, Background, Anatomy' (2024). Available at: https://emedicine.medscape.com/article/1171206-overview (Accessed: 16 April 2025).   Myasthenia Gravis: What Is It? (no date) Cleveland Clinic. Available at: https://my.clevelandclinic.org/health/diseases/17252-myasthenia-gravis-mg (Accessed: 16 April 2025).   Sheikh, S. et al. (2021) ‘Drugs That Induce or Cause Deterioration of Myasthenia Gravis: An Update', Journal of Clinical Medicine, 10(7), p. 1537. Available at: https://doi.org/10.3390/jcm10071537.     Host Bio:                    Ruth Werner is a former massage therapist, a writer, and an NCBTMB-approved continuing education provider. She wrote A Massage Therapist's Guide to Pathology, now in its seventh edition, which is used in massage schools worldwide. Werner is also a long-time Massage & Bodywork columnist, most notably of the Pathology Perspectives column. Werner is also ABMP's partner on Pocket Pathology, a web-based app and quick reference program that puts key information for nearly 200 common pathologies at your fingertips. Werner's books are available at www.booksofdiscovery.com. And more information about her is available at www.ruthwerner.com.      About our Sponsors:   Anatomy Trains: www.anatomytrains.com    American Massage Conference: www.massagetherapymedia/conferences   Earthlite: www.earthlite.com   Anatomy Trains is a global leader in online anatomy education and also provides in-classroom certification programs for structural integration in the US, Canada, Australia, Europe, Japan, and China, as well as fresh-tissue cadaver dissection labs and weekend courses. The work of Anatomy Trains originated with founder Tom Myers, who mapped the human body into 13 myofascial meridians in his original book, currently in its fourth edition and translated into 12 languages. The principles of Anatomy Trains are used by osteopaths, physical therapists, bodyworkers, massage therapists, personal trainers, yoga, Pilates, Gyrotonics, and other body-minded manual therapists and movement professionals. Anatomy Trains inspires these practitioners to work with holistic anatomy in treating system-wide patterns to provide improved client outcomes in terms of structure and function.                      Website: anatomytrains.com                        Email: info@anatomytrains.com             Facebook: facebook.com/AnatomyTrains                       Instagram: www.instagram.com/anatomytrainsofficial   YouTube: https://www.youtube.com/channel/UC2g6TOEFrX4b-CigknssKHA      American Massage Conference Get ready to immerse yourself in the excitement as the American Massage Conference (AMC) arrives to Disney Springs near Orlando, Florida (May 16th-18th, 2025)! With a legacy of 17 successful years in Ontario, Canada, this premier event, proudly hosted by ONE Concept Conferences and expertly produced by Massage Therapy Media (MTM), boasts a lineup of presenters from across the nation and around the globe. The American Massage Conference began in Atlanta in 2011 and has been hosted through the years in San Diego, Chicago, and Virginia Beach. The conference provides educational opportunities with engaging one-, two-, three- and four-hour class formats, networking opportunities, masterminds, MTM Talks, demonstrations, and an extensive exhibitor tradeshow.   Mark your calendars for an unforgettable experience filled with education, networking, and the celebration of massage therapy excellence! ABMP members receive a special discount to attend this in-person conference—log in to your ABMP account to access the discount code and register today. Website: https://www.massagetherapymedia.com/conferences   Earthlite Unlock an exclusive 20 percent discount on all Earthlite products, from portable tables and chairs to professional sheets and oils. Visit earthlite.com, create an account, and enter your ABMP member ID during registration. Plus, enjoy free ground shipping on orders over $75 and a flat rate of $395 for stationary or electric lift tables. (Prices subject to change at any time.) Significant savings on everything you need to enhance your practice. We are proud to assist you as the “World's No. 1 Brand in Massage!”   Sign-up page: https://www.earthlite.com/customer/account/login/referer/aHR0cHM6Ly93d3cuZWFydGhsaXRlLmNvbS8~/  

What's the problem with antibiotics anyway? On this episode of Vitality Radio, Jared passionately answers this question. There is no antibiotic that doesn't cause harm. That's not to say they don't have their place, but as Jared explains, they are almost never necessary and almost always prescribed for common problems like UTI's and sinus infections. You'll learn why many infections don't need, and won't respond to antibiotics, the ramifications of even a single dose of antibiotics, and how antibiotic superbugs are a real problem. Jared delves into why antibiotics are overused, side effects of particularly dangerous forms, and the effects on mental health and the immune system. This show will be followed with one on antibiotic alternatives and ways to rebuild your microbiome after antibiotic exposure.Additional Information:#264: Emotional Vitality: Jen's Story Part 1 - From Addiction and Mental Illness to Vitality#266: Prescribing Poisons Part 2. Ibuprofen, PPI's, and Flouroquinalone AntibioticsVisit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.

On episode #78 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 3/27/25 – 4/9/25. Hosts: Daniel Griffin and Sara Dong Subscribe (free): Apple Podcasts, RSS, email Become a patron of Puscast! Links for this episode Viral Demise of the Milwaukee protocol for rabies (CID) A natural experiment on the effect of herpes zoster vaccination on dementia (Nature) Taking a shot at dementia(microbeTV: TWiV) Recommendations from the 10th European Conference on Infections in Leukaemia for the management of cytomegalovirusin patients after allogeneic haematopoietic cell transplantation and other T-cell-engaging therapies (LANCET: Infectious Diseases) Epstein-Barr virus exposure precedes Crohn`s disease development (Gastroenterology aga) Bacterial Blujepa (gepotidacin) approved by US FDA for treatment of uncomplicated urinary tract infections (uUTIs) in female adults and paediatric patients 12 years of age and older (GSK) GSK wins FDA nod for first oral UTI antibiotic in almost 30 years(BioSpace) Efficacy and safety of individualised versus standard 10-day antibiotic treatment in children with febrile urinary tract infection (INDI-UTI): a pragmatic, open-label, multicentre, randomised, controlled, non-inferiority trial in Denmark (LANCET: Infectious Diseases) Frequency and severity of Myasthenia Gravis exacerbations associated with the use of ciprofloxacin, levofloxacin, and azithromycin (Muscle & Nerve) The cost of blood cultures: a barrier to diagnosis in low-income and middle-income countries (LANCET: Microbe) Rethinking blood culture (LANCET: Microbe) Trends in Anaplasmosis Over the Past Decade: A Review of Clinical Features, Laboratory Data and Outcomes(CID) Fungal The Last of US Season 2 (YouTube) Cracks in the curriculum: the hidden deficiencies in fungal disease coverage in medical books (OFID) Kazachstania slooffiae fungemia: a case report and literature review on an emerging opportunistic pathogen in humans (OFID) Plasma microbial cell-free DNS metagenomic sequencing for diagnosis of invasive fungal diseases among high risk outpatient and inpatient immunocompromised hosts (CID) Parasitic Fatal Case of Splash Pad–Associated Naegleria fowleri Meningoencephalitis — Pulaski County, Arkansas, September 2023 (CDC: MMWR) Notes from the Field: Fatal Acanthamoeba Encephalitis in a patient who regularly used tap water in an electronic nasal irrigation device and a continuous positive airway pressure machine at home — new Mexico, 2023 (CDC: MMWR) Malaria (NEJM) Miscellaneous FDA grants marketing authorization of first home test for chlamydia, gonorrhea and trichomoniasis (FDA) Music is by Ronald Jenkees Information on this podcast should not be considered as medical advice.

Learn from experts in the field on the pharmacist's role in Myasthenia Gravis. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

To mark International Rare Disease Day, we're going to introduce you to a remarkable young woman, Zainab Alani, who is not letting her challenging rare condition stand in the way of her dream of becoming a physician. After noticing Zainab's struggles with muscle weakness and fatigue at age 15, her mother – a physician – took her to doctors advocating for a diagnosis of the rare autoimmune condition generalized myasthenia gravis (MG). Unfortunately, a series of clinicians attributed her symptoms to her menstrual cycle and other errant causes and even accused Zainab of being ‘a lazy teenager.' “Despite having that support and knowledge behind me, these doctors were dismissing my symptoms because of that deceiving label of rare,” Zainab explains to host Lindsey Smith. Wanting to spare others from this frustrating diagnostic odyssey, Zainab turned to advocacy once in medical school and is working with her sister and others through the organization Rare Aware Glasgow to raise awareness among the general public about rare conditions and to spur the medical community to adjust its perspective. “We don't expect medical professionals to know every single rare disease, we just want them to acknowledge their existence and not dismiss them when a family member or a patient brings them up as a differential diagnosis.” In this inspiring episode in our Year of the Zebra podcast series you'll also learn about intersectionality creating burdens in medical diagnosis and a questionable basis for patients being denied access to new treatments.Mentioned in this episode:Rare Aware GlasgowThe Myasthenia Medic If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

In this episode, we review the high-yield topic⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Myasthenia Gravis⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠from the Neurology section at ⁠⁠⁠⁠⁠⁠Medbullets.com⁠⁠⁠⁠⁠⁠Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets

In this episode we will discuss Myasthenia Gravis, an Autoimmune Disease affecting the neuromuscular system of the body with Tasha White, Director of a new Non-profit organization called My Walk with MG located in St. Louis, MO. ​ Myasthenia gravis is a chronic neuromuscular disease that causes weakness in the voluntary muscles. Voluntary muscles include muscles that connect to a person's bones, muscles in the face, throat, and diaphragm. They contract to move the arms and legs and are essential for breathing, swallowing and facial movements. Myasthenia gravis is an autoimmune disease, which means that the body's defense system mistakenly attacks healthy cells or proteins needed for normal functioning. The onset of the disorder may be sudden. Symptoms may not be immediately recognized as myasthenia gravis. The degree of muscle weakness involved varies greatly among individuals.